Zuellig Pharma has been appointed as the exclusive distribution partner for STADA Philippines.
The partnership, effective from 1 January 2024, will see Zuellig Pharma distribute STADA’s range of pharmaceuticals across the Philippines.
Leveraging its established presence in the local market, Zuellig Pharma will manage the distribution of over 70 products, including over-the-counter (OTC) brands, consumer healthcare products, and prescription medicines.
This includes notable brands such as FERN-C vitamin C, Oilatum skincare, and ophthalmic products like Hyabak eye drops. The partnership will also introduce essential generic medicines in therapeutic areas such as antibiotics and cardiovascular care.
The collaboration is expected to enhance access to high-quality healthcare products across pharmacies, supermarkets, hospitals, and clinics in the Philippines. It also supports STADA’s strategic growth plans in Southeast Asia, further strengthening its position in the region.
STADA, with over 125 years of history, is one of Europe’s leading suppliers of medicines and healthcare products, with a strong presence in consumer healthcare and generic medicines. The company is expanding rapidly in emerging markets, including the Philippines, where it aims to solidify its position as a key player.
This partnership underscores the commitment of both companies to improve healthcare accessibility and provide high-quality medicines to communities across the Philippines.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!